Neuralink, Elon Musk's brain implant company, receives FDA approval for human study.

Elon Musk's neurotech startup Neuralink has received FDA approval for its first in-human clinical study of its brain implant called the Link, which aims to help patients with severe paralysis control external technologies using only neural signals. The FDA's approval for an in-human study is a significant win for Neuralink after a series of recent hurdles at the company. Neuralink is part of the emerging brain-computer interface industry, and its BCI will require patients to undergo invasive brain surgery.